BioVision, Inc. Press releases
Jun 18, 2020
To measure Hydroxyurea (HU) concentrations in human serum or plasma.
Jun 17, 2020
For the quantitation of N-Acetylcysteine in biological samples.
May 28, 2020
To monitor total β-Mannosidase activity in various biological samples
May 21, 2020
Sensitive method to detect CD38 activity in a variety of sample types.
May 20, 2020
For conjugating hapten molecules to Activated KLH carrier protein
May 18, 2020
. AbVision, Inc., an innovative biopharmaceutical company, announced today that the Company has developed a biosuperior anti-CD47 therapeutic antibody (AVI-105), powered by its SpeedyAb™ technology platform of therapeutic antibody.
May 06, 2020
AbVision, Inc., an innovative biopharmaceutical company, announced today that the Company has developed a first-in-class COVID-19 vaccine candidate (AVI-205) with an active targeting feature, powered by its patented ImmunoBuster-IITM Active Targeting...
Apr 23, 2020
Screening, characterizing & studying potential inhibitors of Human Glucose 3-Phosphate Dehydrogenase
Apr 22, 2020
Measurement of PAI-1 activity in Biological Samples such as plasma, cell culture medium
Apr 13, 2020
A facile, rapid way to monitor total Alpha-Mannosidase in various biological samples